The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

Standard

The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma. / Borgmann, Mara; Oetting, Agnes; Meyer, Felix; Möckelmann, Nikolaus; Droste, Conrad; von Bargen, Clara Marie; Möller-Koop, Christina; Witt, Melanie; Borgmann, Kerstin; Rothkamm, Kai; Betz, Christian; Münscher, Adrian; Clauditz, Till Sebastian; Rieckmann, Thorsten.

in: J CANCER RES CLIN, Jahrgang 149, Nr. 7, 07.2023, S. 3383-3393.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{6ec7ae10f3b44a32b45b0f47a56d4bee,
title = "The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma",
abstract = "PURPOSE: Immune checkpoint inhibition is a therapeutic option in many cancer entities. In head and neck squamous cell carcinoma (HNSCC) targeting of the PD-1/PD-L1 (B7-H1) axis is approved in recurrent/metastatic disease and is being explored in the curative setting. Here, we evaluated two related members of the B7 family, B7-H3 & B7-H4, for their prognostic impact under standard treatment.METHODS: A tissue microarray (TMA) of a single center HNSCC cohort was stained for B7-H3 and B7-H4. Staining intensity and the number of tumor cells stained were assessed, and the expression was scored according to an established algorithm. Staining scores were correlated with clinicopathological parameters and associated with patient survival. mRNA levels of both proteins were associated with patient outcome using the TCGA dataset.RESULTS: mRNA levels of B7-H3 and B7-H4 were not significantly associated with patient survival. TMA analysis revealed interpretable protein staining in 408 samples. Strong staining was the most frequent category for B7-H3 and no staining for B7-H4. In patients with p16-negative oropharyngeal SCC (OPSCC) and in a pooled cohort consisting of p16-negative OPSCC, laryngeal, hypopharyngeal and oral cavity SCC, strong B7-H3 expression was associated with better overall survival. For the latter cohort, this was in part due to reduced lymph node involvement. B7-H3 expression in p16-positive OPSCC and B7-H4 expression were not associated with outcome.CONCLUSION: Despite a possible role in tumor immune escape, B7-H3 was associated with favorable prognosis in HPV-negative HNSCC in our cohort. The underlying mechanisms and a potential impact for B7-H3 targeting remain to be elucidated.",
author = "Mara Borgmann and Agnes Oetting and Felix Meyer and Nikolaus M{\"o}ckelmann and Conrad Droste and {von Bargen}, {Clara Marie} and Christina M{\"o}ller-Koop and Melanie Witt and Kerstin Borgmann and Kai Rothkamm and Christian Betz and Adrian M{\"u}nscher and Clauditz, {Till Sebastian} and Thorsten Rieckmann",
note = "{\textcopyright} 2022. The Author(s).",
year = "2023",
month = jul,
doi = "10.1007/s00432-022-04244-2",
language = "English",
volume = "149",
pages = "3383--3393",
journal = "J CANCER RES CLIN",
issn = "0171-5216",
publisher = "Springer",
number = "7",

}

RIS

TY - JOUR

T1 - The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

AU - Borgmann, Mara

AU - Oetting, Agnes

AU - Meyer, Felix

AU - Möckelmann, Nikolaus

AU - Droste, Conrad

AU - von Bargen, Clara Marie

AU - Möller-Koop, Christina

AU - Witt, Melanie

AU - Borgmann, Kerstin

AU - Rothkamm, Kai

AU - Betz, Christian

AU - Münscher, Adrian

AU - Clauditz, Till Sebastian

AU - Rieckmann, Thorsten

N1 - © 2022. The Author(s).

PY - 2023/7

Y1 - 2023/7

N2 - PURPOSE: Immune checkpoint inhibition is a therapeutic option in many cancer entities. In head and neck squamous cell carcinoma (HNSCC) targeting of the PD-1/PD-L1 (B7-H1) axis is approved in recurrent/metastatic disease and is being explored in the curative setting. Here, we evaluated two related members of the B7 family, B7-H3 & B7-H4, for their prognostic impact under standard treatment.METHODS: A tissue microarray (TMA) of a single center HNSCC cohort was stained for B7-H3 and B7-H4. Staining intensity and the number of tumor cells stained were assessed, and the expression was scored according to an established algorithm. Staining scores were correlated with clinicopathological parameters and associated with patient survival. mRNA levels of both proteins were associated with patient outcome using the TCGA dataset.RESULTS: mRNA levels of B7-H3 and B7-H4 were not significantly associated with patient survival. TMA analysis revealed interpretable protein staining in 408 samples. Strong staining was the most frequent category for B7-H3 and no staining for B7-H4. In patients with p16-negative oropharyngeal SCC (OPSCC) and in a pooled cohort consisting of p16-negative OPSCC, laryngeal, hypopharyngeal and oral cavity SCC, strong B7-H3 expression was associated with better overall survival. For the latter cohort, this was in part due to reduced lymph node involvement. B7-H3 expression in p16-positive OPSCC and B7-H4 expression were not associated with outcome.CONCLUSION: Despite a possible role in tumor immune escape, B7-H3 was associated with favorable prognosis in HPV-negative HNSCC in our cohort. The underlying mechanisms and a potential impact for B7-H3 targeting remain to be elucidated.

AB - PURPOSE: Immune checkpoint inhibition is a therapeutic option in many cancer entities. In head and neck squamous cell carcinoma (HNSCC) targeting of the PD-1/PD-L1 (B7-H1) axis is approved in recurrent/metastatic disease and is being explored in the curative setting. Here, we evaluated two related members of the B7 family, B7-H3 & B7-H4, for their prognostic impact under standard treatment.METHODS: A tissue microarray (TMA) of a single center HNSCC cohort was stained for B7-H3 and B7-H4. Staining intensity and the number of tumor cells stained were assessed, and the expression was scored according to an established algorithm. Staining scores were correlated with clinicopathological parameters and associated with patient survival. mRNA levels of both proteins were associated with patient outcome using the TCGA dataset.RESULTS: mRNA levels of B7-H3 and B7-H4 were not significantly associated with patient survival. TMA analysis revealed interpretable protein staining in 408 samples. Strong staining was the most frequent category for B7-H3 and no staining for B7-H4. In patients with p16-negative oropharyngeal SCC (OPSCC) and in a pooled cohort consisting of p16-negative OPSCC, laryngeal, hypopharyngeal and oral cavity SCC, strong B7-H3 expression was associated with better overall survival. For the latter cohort, this was in part due to reduced lymph node involvement. B7-H3 expression in p16-positive OPSCC and B7-H4 expression were not associated with outcome.CONCLUSION: Despite a possible role in tumor immune escape, B7-H3 was associated with favorable prognosis in HPV-negative HNSCC in our cohort. The underlying mechanisms and a potential impact for B7-H3 targeting remain to be elucidated.

U2 - 10.1007/s00432-022-04244-2

DO - 10.1007/s00432-022-04244-2

M3 - SCORING: Journal article

C2 - 35941227

VL - 149

SP - 3383

EP - 3393

JO - J CANCER RES CLIN

JF - J CANCER RES CLIN

SN - 0171-5216

IS - 7

ER -